… new formulations of dipyridamole (DP), a pH-dependent poorly soluble drug, employing an
acidic pH-modifier … Granule formulations of DP (DPG) with and without fumaric acid (FA) were …

… -releases formulation of DP with pH-modifier for enhancing … formulations of DP (DPG) with
seven acidic pH-modifiers … Selection of appropriate acid and formulation optimization were …

… of dipyridamole, a poorly soluble weakly basic compound. The solubility of dipyridamole
is … were formulated containing organic acids as pH modifiers to regulate micro-environmental …

… a pH-independent release formulation of dipyridamole (DP) by the combined use of pH-modifier …
Tartaric acid (TA) was selected as an appropriate pH-modifier in terms of improving the …

… polymer in solid dispersion formulations [22,… is pH-dependent could be improved by pH-modifier
technology [24]. Organic acids as pH-modifiers could reduce the microenvironmental pH …

… They included fumaric acid as a pH-modifier 18 because fumaric acid was reported not to
form a salt with dipyridamole. In this study, various formulations of dipyridamole including …

… The dipyridamole-acidifier formulations were prepared by … formulations, a pH-shift dissolution
test from pH 1.2 to neutral … of acidifier-based formulations containing dipyridamole, a model …

… novel pH independent extended Dipyridamole tablets. Drug release is found completely pH
… importance of pH independent extended releases formulations with pH modulating agent, …

… excipients as a pH-modifier in the formulation, leading to pH-independent solubility. In the …
) were selected as appropriate pH-modifiers among ten acids for dipyridamole IR granules. A …

… at the preparation of a pH-independent sustained-release dosage form of dipyridamole,
the evaluation of the influence of gastric acidity on the bioavailability of dipyridamole and the …